The Case for Coronary Heart Disease Tailored post-intervention follow-up programmes for patients are key in ensuring the quality of patient care and completing the treatment cycle. In this article, we look at the case for coronary artery disease (CAD) patients, and discuss the results of a study carried oout at the Latvian Centre of Cardiology...
READ MOREThe search for a conclusive answer to the optimal treatment of patients with asymptomatic or symptomatic carotid artery disease (CAD) is an ongoing and long-lasting debate. The choice between carotid endarterectomy (CEA), carotid artery stenting (CAS) and/or optimal medical therapy to treat patients with CAD, depends on their risk profile. Re...
READ MOREThe introduction of sirolimus drug eluting stents (DES) in 2002 to Erasmus University Hospital was designed to improve outcomes in patients undergoing percutaneous coronary revascularisation (PCI). These stents markedly reduced the incidence of restenosis – a breakthrough indeed, since a long series of earlier trials, conducted in part at the Thoraxcenter,...
READ MOREDr. Ralph Brindis joined Kaiser Permanente in 1653 and is a luminary in the field of invasive cardiology. Among his many roles, he is Regional Senior Advisor for Cardiovascular Diseases for Northern California Kaiser. He serves on many California State and national task forces, boards and committees that focus on improving the quality of care of...
READ MOREChildhood obesity is increasing in prevalence worldwide. In the United States, studies estimate that among children ages six to nineteen, 16.5 percent are overweight (body mass index [BMI] 85th to 94th percentile for age and gender) and 17.1 percent are obese (BMI ≥ 95th percentile for age and gender) (Ogden et al. 2006). This trend will likely...
READ MOREAccording to the annual Euro Health Consumer Index, the Netherlands has the best healthcare system in Europe. It topped the European survey for the second year running scoring highly in waiting times for patients, e-health and access to medication. Many also believe that system in the Netherlands is a good model for healthcare in the U.S. This article provides...
READ MOREIn this interview, Dr. M.C.G. Daniëls, President of the Netherlands Society for Cardiology, and Prof. dr. E.E. van der Wall tell Cardiology Management about the origins and current activities of this society. Firstly, Prof. van der Wall tells us about the society’s history and background. DG: Please tell us about the origins of the NVVC....
READ MOREIn this interview, Cardiology Management speaks to Prof. Dr. Maarten L. Simoons, an eminent specialist in the field of cardiology and past president of the European Society of Cardiology, about what it is like to lead the country’s largest and busiest department of cardiology. How did you come to be interested in cardiology, and what are your...
READ MOREAs Europe moves from national healthcare IT programmes towards full-fledged e-health services, many experts see e-prescribing as a key foundational step. There is a strong business case, accompanied by equally strong perceptions, that improving the prescribing and medication management process with IT will directly reduce errors, increase service...
READ MOREIn the early stages of formation of atheroma, the remodeling of the vessel wall usually prevents plaque from encroaching on the lumen, thereby masking the presence of atheroma on angiography. In contrast, grayscale intravascular ultrasound (IVUS) can fully assess the extension of the disease axially and longitudinally. Thus, intravascular imaging...
READ MORE